Brain Tumor Diagnostics and Therapeutics Market Outlook, Competitive analysis, Industry Trends 2017 - 2025
The global market for the diagnostics and therapeutics is gaining traction from a number of factors, such as increasing prevalence of brain cancer, innovations in drug delivery to brain cancer cells, and widespread market for the treatment of brain cancer as well as its associated symptoms. On the other hand, the lack of brain cancer specific drugs, increasing use of generics in chemotherapy, and utterly high cost of brain tumor diagnosis and treatment are a few important challenges faced by the market before attaining its true potential. Nevertheless, in the near future, the vendors of this market are expected to gain new opportunities by improving the technology to reach the cancer tumor at unreachable parts of the brain, although surgery currently remains the most effective mode of treatment.
Based on cancer type, the global brain tumor diagnostics and therapeutics market can be segment into glioma including oligodendroglioma, astrocytoma, choroid plexus papilloma, and ependymoma, medulloblastoma, meningioma, schwannomas, and pituitary adenoma. On the basis of therapeutics, this market can be categorized into brain cancer including radiation therapy, chemotherapy, and targeted therapy. Geographically, the report takes stock of the potential of all important regions such as North America, Asia Pacific, and Europe.
Request Sample Copy of the Report @ www.tmrresearch.com/sample/sample?flag=B&rep_id=1181
This report on the global brain tumor diagnostics and therapeutics market has been developed by a group of professional market research analysts, with a solitary goal to represent the current scenario as well as the future prospects of the market to the stakeholders connected to the value chain. A number of leading companies operating in this market have also been profiled to highlight the competitive landscape.
Global Brain Tumor Diagnostics and Therapeutics Market: Overview
Increased prevalence of symptoms associated with brain tumor has led to a growing demand for tests detecting the presence of tumors. Some of the common types of tests used for the diagnosis of brain tumor are magnetic resonance imaging (MRI), myelogram, electroencephalography (EEG), tissue sampling or biopsy of surgical removal of a tumor, CT scan, cerebral angiogram or cerebral anteriogram, molecular testing, positron emission tomography (also called PET or PET-CT scan), and neurocognitive assessment.
The growth drivers, opportunities, deterrents, and recent developments in the global market for brain tumor diagnostics and therapeutics have been analyzed in details. The report presents value chain analysis, the supply and demand ratio, market attractiveness, and the past and projected leading market segments. The prominent vendors have been evaluated in depth, considering their market shares, product portfolios, and recent business strategies.
Request TOC of the Report @ www.tmrresearch.com/sample/sample?flag=T&rep_id=1181
Global Brain Tumor Diagnostics and Therapeutics Market: Drivers and Restraints
Recently, the healthcare sector has been displaying increasing public-private partnerships. These partnerships will prove to be beneficial for the growth of the global brain tumor diagnostics and therapeutics market as they are contributing towards the modernization of radiology and diagnostic imaging services. Research activities in the area of molecular diagnostics aimed at understanding cell biology and recognizing gene mutations related to malignancy are expected to boost growth. Technological advancements, increasing consumer base, advanced healthcare infrastructures, and growing health awareness among people are some of the major growth drivers of the global brain tumor diagnostics and therapeutics market.
On the other hand, the high cost of these tests and lack of trained personnel might restrain the growth of the global brain tumor diagnostics and therapeutics market. Nevertheless, opportunities are likely to materialize from the emergence of new technologies such as chemical exchange saturation transfer (CEST) and sodium magnetic resonance imaging (Na MRI). These technologies not only aid in the diagnosis of tumors, but also in therapies treating them.
Based on types of tumor, the anaplastic astrocytoma, anaplastic oligodendroglioma, low-grade (diffuse) astrocytoma, ependymoma, glioblastoma, and oligodendroglioma can be the major segments.
Read Comprehensive Overview of Report@ www.tmrresearch.com/brain-tumor-diagnostics-therapeutics-...
Global Brain Tumor Diagnostics and Therapeutics Market: Regional Outlook
Based on region, the global brain tumor diagnostics and therapeutics market can be segmented into the Middle East and Africa, Latin America, North America, Asia Pacific, and Europe. North America, with the U.S at the forefront, is expected to witness significant growth. The increasing demand for brain tumor diagnostics and therapeutics from this region can be attributed to the rising incidence of brain tumors. According to the Central Brain Tumor Registry, the U.S. might witness approximately 79,270 new cases of primary non-malignant and malignant brain and CNS tumors by the end of 2017.
Furthermore, Asia Pacific is slated to expand considerably over the forecast period, as the awareness about the availability and significance of these tests is gradually spreading. The healthcare expenditures and per capita incomes of people in countries across Asia Pacific are also rising, promising further expansion of the brain tumor diagnostics and therapeutics market in the region.
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.
Head - Internet Marketing
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Brain Tumor Diagnostics and Therapeutics Market Outlook, Competitive analysis, Industry Trends 2017 - 2025 here
News-ID: 629833 • Views: 195
More Releases from TMR Research
Overview On Upcoming Need 2025: Dyslipidemia drugs Market |AstraZeneca, Aegerion …
Global Dyslipidemia Drugs Market: Snapshot Dyslipidemia is a cardiovascular condition comprising of changes in the amount of lipids in the blood. Dyslipidemia can show as either absence of or abundance of lipids in blood; hyperlipidemia, the state of having overabundance lipids in the blood, is probably going to hold the major share in the global dyslipidemia drugs market in the within the forecast period. Various issues related with dietary habits and
Intravenous Iron Drugs Market 2017-2025 | Fresenius Medical Care AG & Co. KGaA, …
Intravenous Iron Drugs Market: Snapshot Iron is one of the most significant minerals required for the correct working of human bodies. Iron insufficiency prompts various medical problems, for example, anemia and could have a grave and direct association with the several of hospitalizations and deaths. The global market for intravenous drugs is foreseen to display a solid CAGR over the report's forecast period attributable to the rising pervasiveness of anemia cases
E-Clinical Solution Software Market Detailed Global Analysis and Forecast 2017-2 …
Global E-Clinical Solution Software Market: Snapshot The current advances in the healthcare industry is witnessing an increasingly connected and technology-advanced operational infrastructure. This has led to it becoming one of the largest producers of sensitive and personal data about the numerous patients it caters to daily. Hospitals, clinics, laboratories, insurance companies and other medical networks are swamped with gargantuan amount of patient information. This has generated an urgent need to create
Nuclear Decommissioning Services Market 2017-2025 | Babcock International Group …
Global Nuclear Decommissioning Services Market: Snapshot The demand in the global market for nuclear decommissioning market is driven by a number of factors including accidents and rising political pressure for pre-closure, stringent regulations since Fukushima accident, public and government support for decommissioning of nuclear reactors, worldwide shut down of older reactors, and increase in the use of renewable energy. On the other hand, stringent regulatory standards, reliability of nuclear power, difficulty
More Releases for Brain
4th International conference on Brain Disorders and Brain Injury
Dear Members, I hope you are doing well This is Karlin Zoe; we would like to invite at our upcoming 4th International Conference on Brain Disorder and Brain Injury on August 14-16, 2017 at Toronto, Canada Participate at this conference and earn up to 20 AMA PRA Category 1 Credits TM Mark your calendar as busy on August 14-16, 2017; they are the official dates for the Brain Injury 2017. Participation benefits: Claim CME
Brain Computer Interface Devices Helps in Curing Brain-Related Disorders
The increasing technological adoption of wearable medical devices is expected to positively support the market for brain computer interface (BCI) technology. The demand for BCI devices is expected to increase primarily in the health care and gaming and entertainment industries. Ageing induces brain-related disorders such as stroke, depression, and Parkinson’s disease. These disorders can be treated with the use of BCI devices. Therefore, the ageing population is one of the
Educating The Female Brain
The growth of the female brain starts it on its unique growth pattern almost from conception which results in significant differences in what females need in schools and their lives as they grow up to educate the female brain. "Almost from conception, the female brain is bathed in estrogen which produces different needs in a female as opposed to the impact of the testosterone bath experienced by males," explained Elizabeth Guarnaccia,
The Aging Brain
Aging begins the moment we are born, as internal and external factors work together to rapidly shape our human experience. Which physiological and psychological factors contribute to cognitive development in youth, and which contribute to degradation as we age? Where do biological and cultural components meet and overlap to shape our cognition, and how does aging affect brain development and memory? Can we actively impact our own brain plasticity? At this
Now Available – Brain Supreme
Brain Supreme is a great new product that is used to handle proper brain health. This product is used to help with ensuring that the brain is able to work with the right possible nutrition. Getting this product to work will be very easy for anyone to handle. Brain Supreme is a product that works as a brain function enhancer. It uses a series of different ingredients for brain functions.
ReelTime Gets Brain Damage
(Cannes, France - October 15, 2007)– ReelTime.com (PINKSHEETS: RLTR)– the video-on-demand broadband network, announced at MIPCOM that they have concluded an agreement with Maxim Media International to license forty films from Maxim’s Brain Damage Films of horror and gore films according to Beverly Zaslow, president and COO of ReelTime. ReelTime will add an additional ten films a month to its library during the term of the agreement. ReelTime.com offers high